000			02394cam a22005054a 4500
999			_c3304 _d3304
001			14294124
003			OSt
005			20191003170053.0
008			060309s2006 nyuaf b 001 0 eng
010			_a 2006040302
015			_2bnb _aGBA646485
016	7		_a101271635 _2DNLM
016	7		_a013464661 _2Uk
020			_a0824728971 (Hardcover : alk. paper)
020			_a9780824728977
035			_a(OCoLC)ocm65195279
040			_aDNLM/DLC _cDLC _dNLM _dBAKER _dUKM _dC#P _dDLC
042			_apcc
050	0	0	_aRC521 _b.D459 2006
060	0	0	_a2006 J-224
060	1	0	_aWM 220 _bD376393 2006
082	0	0	_a616.830 75 HER _223
245	0	4	_aThe dementias : _bearly diagnosis and evaluation / _cedited by Karl Herholz, Daniela Perani, Chris Morris.
260			_aNew York : _bTaylor & Francis, _c2006.
300			_axv, 455 p., [8] p. of plates : _bill. (some col.) ; _c24 cm.
504			_aIncludes bibliographical references and index.
505			_aThe Clinical Issues. Neuropsychological Screening and Advanced Neuropsychological Tests. Biomarkers in Blood and Cerebrospinal Fluid. Genetics: Facts and Perspectives. Approaches to the Identification of Novel Diagnostic and Therapeutic Targets in Dementia. Quantitative and Functional MRI Techniques. Perfusion SPECT. FDG PET: Imaging Cerebral Glucose Metabolism with Positron Emission Tomography. Imaging of Neurotransmitter Systems in Dementia. Development and Application of beta-Amyloid Imaging Agents in Alzheimer's Disease. A View on Early Diagnosis of Dementias from Neuropathology. Guideline and Perspective. Index
650		0	_aDementia _xDiagnosis.
650		0	_aNeuropsychological tests.
650		0	_aBiochemical markers.
650		0	_aDiagnostic imaging.
650	1	2	_aDementia _xdiagnosis.
650	1	2	_aDementia _xetiology.
650	2	2	_aBiological Markers.
650	2	2	_aDiagnostic Imaging _xmethods.
650	2	2	_aEarly Diagnosis.
650	2	2	_aNeuropsychological Tests.
700	1		_aHerholz, K. _q(Karl)
700	1		_aPerani, Daniela.
700	1		_aMorris, Chris, _d1965-
856	4	2	_3Publisher description _uhttp://www.loc.gov/catdir/enhancements/fy0648/2006040302-d.html
906			_a7 _bcbc _corignew _d1 _eocip _f20 _gy-gencatlg
942			_2ddc _cSTS